Frontiers in Oncology,
Год журнала:
2020,
Номер
10
Опубликована: Дек. 15, 2020
A
metabolic
shift
from
oxidative
phosphorylation
(OXPHOS)
to
glycolysis—known
as
the
Warburg
effect—is
characteristic
for
many
cancers.
It
gives
cancer
cells
a
survival
advantage
in
hypoxic
tumor
microenvironment
and
protects
them
cytotoxic
effects
of
damage
apoptosis.
The
main
regulators
this
are
pyruvate
dehydrogenase
complex
kinase
(PDK)
isoforms
1–4.
PDK
is
known
be
overexpressed
several
cancers
associated
with
bad
prognosis
therapy
resistance.
Whereas
expression
PDK1–3
tissue
specific,
PDK4
dependent
on
energetic
state
whole
organism.
In
contrast
other
isoforms,
not
only
oncogenic,
but
also
suppressive
functions
have
been
reported.
tumors
that
profit
high
OXPHOS
de
novo
fatty
acid
synthesis,
can
protective
effect.
This
case
prostate
cancer,
most
common
men,
makes
an
interesting
therapeutic
target.
While
work
focused
characterized
by
glycolytic
activity,
little
research
devoted
those
cases
where
acts
therefore
highly
needed.
Journal of Experimental & Clinical Cancer Research,
Год журнала:
2020,
Номер
39(1)
Опубликована: Июль 6, 2020
Abstract
Liver
cancer
has
become
the
sixth
most
diagnosed
and
fourth
leading
cause
of
death
worldwide.
Hepatocellular
carcinoma
(HCC)
is
responsible
for
up
to
75–85%
primary
liver
cancers,
sorafenib
first
targeted
drug
advanced
HCC
treatment.
However,
resistance
common
because
resultant
enhancement
aerobic
glycolysis
other
molecular
mechanisms.
Aerobic
was
firstly
found
in
HCC,
acts
as
a
hallmark
regulation
proliferation,
immune
evasion,
invasion,
metastasis,
angiogenesis,
HCC.
The
three
rate-limiting
enzymes
glycolytic
pathway,
including
hexokinase
2
(HK2),
phosphofructokinase
1
(PFK1),
pyruvate
kinases
type
M2
(PKM2)
play
an
important
role
can
be
regulated
by
many
mechanisms,
such
AMPK,
PI3K/Akt
HIF-1α,
c-Myc
noncoding
RNAs.
Because
importance
progression
targeting
key
factors
its
pathway
inhibition
HK2,
PFK
or
PKM2,
represent
potential
new
therapeutic
approaches
treatment
Proceedings of the National Academy of Sciences,
Год журнала:
2019,
Номер
116(9), С. 3909 - 3918
Опубликована: Фев. 7, 2019
Metabolic
plasticity
enables
cancer
cells
to
switch
their
metabolism
phenotypes
between
glycolysis
and
oxidative
phosphorylation
(OXPHOS)
during
tumorigenesis
metastasis.
However,
it
is
still
largely
unknown
how
orchestrate
gene
regulation
balance
OXPHOS
activities.
Previously,
by
modeling
the
of
we
have
reported
that
can
acquire
a
stable
hybrid
metabolic
state
in
which
both
be
used.
Here,
comprehensively
characterize
activity,
establish
theoretical
framework
coupling
with
pathways.
Our
results
demonstrate
direct
association
activities
AMPK
HIF-1,
master
regulators
glycolysis,
respectively,
three
major
pathways:
glucose
oxidation,
fatty
acid
oxidation.
model
further
characterizes
metabolically
inactive
where
low
activity
OXPHOS.
We
verify
prediction
using
metabolomics
transcriptomics
data
from
paired
tumor
adjacent
benign
tissue
samples
cohort
breast
patients
RNA-sequencing
The
Cancer
Genome
Atlas.
validate
vitro
studies
aggressive
triple-negative
(TNBC)
cells.
experimental
confirm
TNBC
maintain
phenotype
targeting
necessary
eliminate
plasticity.
In
summary,
our
work
serves
as
platform
symmetrically
study
tuning
modulates
pathway
vice
versa.
British Journal of Pharmacology,
Год журнала:
2016,
Номер
173(6), С. 970 - 979
Опубликована: Янв. 11, 2016
:
The
Warburg
effect
describes
the
increased
utilization
of
glycolysis
rather
than
oxidative
phosphorylation
by
tumour
cells
for
their
energy
requirements
under
physiological
oxygen
conditions.
This
has
been
basis
much
speculation
on
survival
advantage
cells,
tumourigenesis
and
microenvironment
tumours.
More
recently,
studies
have
begun
to
reveal
how
could
influence
drug
efficacy
our
understanding
energetics
be
exploited
improve
development.
In
particular,
evidence
is
emerging
demonstrating
better
modelling
metabolic
lead
a
prediction
identification
new
combination
strategies.
review
will
provide
details
current
complex
interplay
between
glucose
metabolism
pharmacology
discuss
opportunities
utilizing
in
future
Cell Death and Disease,
Год журнала:
2019,
Номер
10(4)
Опубликована: Апрель 5, 2019
Accumulating
evidence
suggests
that
aerobic
glycolysis
is
important
for
colorectal
cancer
(CRC)
development.
However,
the
underlying
mechanisms
have
yet
to
be
elucidated.
B7-H3,
an
immunoregulatory
protein,
broadly
overexpressed
by
multiple
tumor
types
and
plays
a
vital
role
in
progression.
In
this
study,
we
found
overexpression
of
B7-H3
effectively
increased
rate
glucose
consumption
lactate
production,
whereas
knockdown
had
opposite
effect.
Furthermore,
showed
production
promoting
hexokinase
2
(HK2)
expression
CRC
cells,
also
HK2
was
key
mediator
B7-H3-induced
chemoresistance.
Depletion
or
treating
cells
with
inhibitors
could
reverse
increase
B7-H3-endowed
chemoresistance
cells.
Moreover,
verified
positive
correlation
between
tissues
patients.
Collectively,
our
findings
suggest
may
novel
regulator
metabolism
via
controlling
result
help
develop
as
promising
therapeutic
target
treatment.
Cancers,
Год журнала:
2018,
Номер
10(12), С. 471 - 471
Опубликована: Ноя. 28, 2018
The
progression
of
cancer
is
associated
with
alterations
in
the
tumor
microenvironment,
including
changes
extracellular
matrix
(ECM)
composition,
rigidity,
hypervascularization,
hypoxia,
and
paracrine
factors.
One
key
malignant
phenotype
cells
their
ability
to
resist
chemotherapeutics,
elements
ECM
can
promote
chemoresistance
through
a
variety
signaling
pathways,
inducing
gene
expression
protein
activity
that
allow
resistance.
Furthermore,
maintained
as
an
environment
facilitates
chemoresistance,
since
its
constitution
modulates
cancer-associated
cells,
which
themselves
affect
microenvironment.
In
this
review,
we
discuss
how
properties
microenvironment
interplay
between
these
external
stimuli.
We
focus
on
both
response
environment,
well
maintenance
chemoresistant
emerges
from
complex
network
present.
Journal of Experimental & Clinical Cancer Research,
Год журнала:
2020,
Номер
39(1)
Опубликована: Янв. 30, 2020
Hepatocellular
carcinoma
(HCC)
is
a
common
primary
malignant
tumor
which
usually
progresses
to
an
advanced
stage
because
of
late
diagnosis.
Sorafenib
(Sora)
first
line
medicine
for
HCC;
however,
it
has
been
faced
with
enormous
resistance.
Simvastatin
(Sim)
cholesterol-lowering
drug
and
reported
inhibit
growth.
The
present
study
aims
determine
whether
Sora
Sim
co-treatment
can
improve
resistance
in
HCC.The
HCC
cell
LM3
established
Sora-resistant
(LM3-SR)
were
used
the
relationship
between
aerobic
glycolysis.
Cell
proliferation,
apoptosis
glycolysis
levels
analyzed
by
western
blotting,
flow
cytometry
analysis
biomedical
tests.
A
xenograft
model
was
also
examine
effect
vivo.
Detailed
mechanistic
studies
undertaken
use
activators
inhibitors,
lentivirus
transfections.Our
results
demonstrated
that
associated
enhanced
levels.
Furthermore,
LM3-SR
cells
more
sensitive
than
cells,
suggesting
combined
treatment
both
could
enhance
sensitivity
Sora.
This
finding
may
be
due
suppression
HIF-1α/PPAR-γ/PKM2
axis.Simvastatin
axis,
suppressing
PKM2-mediated
glycolysis,
resulting
decreased
proliferation
increased
re-sensitizing
International Journal of Molecular Sciences,
Год журнала:
2021,
Номер
22(16), С. 8885 - 8885
Опубликована: Авг. 18, 2021
Cancer
cells
utilise
several
mechanisms
to
increase
their
survival
and
progression
as
well
resistance
anticancer
therapy:
deregulation
of
growth
regulatory
pathways
by
acquiring
grow
factor
independence,
immune
system
suppression,
reducing
the
expression
antigens
activating
T
lymphocyte
(mimicry),
induction
anti-apoptotic
signals
counter
action
drugs,
activation
DNA
repair
driving
active
efflux
drugs
from
cell
cytoplasm,
epigenetic
regulation
microRNAs
(miRNAs).
Because
it
is
commonly
diagnosed
late,
lung
cancer
remains
a
major
malignancy
with
low
five-year
rate;
when
diagnosed,
often
highly
advanced,
may
have
acquired
drug
resistance.
This
review
summarises
main
involved
in
cisplatin
interactions
between
cisplatin-resistant
tumour
microenvironment.
It
also
analyses
changes
gene
profile
sensitive
vs.
non-small
(NSCLC)
cellular
model
using
GSE108214
Gene
Expression
Omnibus
database.
describes
protein-protein
interaction
network
that
indicates
dysregulated
TP53,
MDM2,
CDKN1A
genes
they
encode
top
networking
proteins
be
tolerance,
these
all
being
upregulated
cells.
Furthermore,
illustrates
multifactorial
nature
examining
diversity
present
NSCLC
based
on
KEGG
pathway
analysis.
Signal Transduction and Targeted Therapy,
Год журнала:
2024,
Номер
9(1)
Опубликована: Май 27, 2024
Notch
signaling,
renowned
for
its
role
in
regulating
cell
fate,
organ
development,
and
tissue
homeostasis
across
metazoans,
is
highly
conserved
throughout
evolution.
The
receptor
ligands
are
transmembrane
proteins
containing
epidermal
growth
factor-like
repeat
sequences,
typically
necessitating
receptor-ligand
interaction
to
initiate
classical
signaling
transduction.
Accumulating
evidence
indicates
that
the
pathway
serves
as
both
an
oncogenic
factor
a
tumor
suppressor
various
cancer
types.
Dysregulation
of
this
promotes
epithelial-mesenchymal
transition
angiogenesis
malignancies,
closely
linked
proliferation,
invasion,
metastasis.
Furthermore,
contributes
maintaining
stem-like
properties
cells,
thereby
enhancing
invasiveness.
regulatory
metabolic
reprogramming
microenvironment
suggests
pivotal
involvement
balancing
suppressive
effects.
Moreover,
implicated
conferring
chemoresistance
cells.
Therefore,
comprehensive
understanding
these
biological
processes
crucial
developing
innovative
therapeutic
strategies
targeting
signaling.
This
review
focuses
on
research
progress
cancers,
providing
in-depth
insights
into
potential
mechanisms
regulation
occurrence
progression
cancer.
Additionally,
summarizes
pharmaceutical
clinical
trials
therapy,
aiming
offer
new
human
malignancies.
Cancer Communications,
Год журнала:
2022,
Номер
42(3), С. 245 - 265
Опубликована: Март 1, 2022
Abstract
Background
Chemotherapy
resistance
is
a
primary
reason
of
ovarian
cancer
therapy
failure;
hence
it
important
to
investigate
the
underlying
mechanisms
chemotherapy
and
develop
novel
potential
therapeutic
targets.
Methods
RNA
sequencing
cisplatin‐resistant
‐sensitive
(chemoresistant
chemosensitive,
respectively)
organoids
was
performed,
followed
by
detection
expression
level
fibrillin‐1
(FBN1)
in
clinical
specimens
cancer.
Subsequently,
glucose
metabolism,
angiogenesis,
chemosensitivity
were
analyzed
structural
glycoprotein
FBN1‐knockout
cell
lines.
To
gain
insights
into
specific
functions
action
FBN1
cancer,
immunoprecipitation,
silver
nitrate
staining,
mass
spectrometry,
immunofluorescence,
Western
blotting,
Fӧrster
resonance
energy
transfer‐fluorescence
lifetime
imaging
analyses
vivo
assays
using
vertebrate
model
systems
nude
mice
zebrafish.
Results
significantly
enhanced
tissues,
indicating
that
might
be
key
factor
chemoresistance
We
also
discovered
sustained
stress
induced
angiogenesis
vitro
vivo,
which
promoted
cisplatin‐resistance
Knockout
combined
with
treatment
antiangiogenic
drug
apatinib
improved
cisplatin‐sensitivity
cells.
Mechanistically,
mediated
phosphorylation
vascular
endothelial
growth
receptor
2
(VEGFR2)
at
Tyr1054
residue,
activated
its
downstream
focal
adhesion
kinase
(FAK)/protein
B
(PKB
or
AKT)
pathway,
signal
transducer
activator
transcription
(STAT2)
tyrosine
residue
690
(Tyr690),
nuclear
translocation
STAT2,
ultimately
altered
genes
associated
STAT2‐mediated
glycolysis.
Conclusions
The
FBN1/VEGFR2/STAT2
signaling
axis
may
induce
cells
participating
process
glycolysis
angiogenesis.
present
study
suggested
FBN1‐targeted
and/or
combination
inhibition
for
treating
Biomedicine & Pharmacotherapy,
Год журнала:
2023,
Номер
159, С. 114301 - 114301
Опубликована: Янв. 25, 2023
Cuproptosis,
a
novel
copper-induced
cell
death
pathway,
is
linked
to
mitochondrial
respiration
and
mediated
by
protein
lipoylation.
The
discovery
of
cuproptosis
unfolds
new
areas
investigation,
particularly
in
cancers.
present
study
aimed
explore
the
role
colorectal
cancer
progression.
genetic
alterations
colon
were
evaluated
using
database.
MTT
assays,
colony
formation,
flow
cytometry
used
examine
effect
elesclomol-Cu
4-Octyl
itaconate
(4-OI)
on
oxaliplatin-resistant
viability.
anti-tumor
elesclomol
with
4-OI
was
verified
vivo
assay.
results
showed
that
FDX1,
SDHB,
DLAT,
DLST
genes
more
highly
expressed
normal
tissues
than
those
primary
tumor
tissues.
Patients
high
expressions
these
had
better
prognosis.
Using
assay
formation
analysis,
pulse
treatment
significant
inhibition
viability
HCT116,
LoVo,
HCT116-R
cells.
In
addition,
revealed
significantly
promoted
apoptosis.
Tetrathiomolybdate,
copper
chelator,
markedly
inhibited
cuproptosis.
Subsequently,
we
found
2-deoxy-D-glucose,
glucose
metabolism
inhibitor,
sensitized
Furthermore,
galactose
further
Interestingly,
enhanced
which
irrelevant
ROS
production,
apoptosis,
necroptosis,
or
pyroptosis
pathways.
Aerobic
glycolysis
through
GAPDH,
one
key
enzymes
glycolysis,
sensitizing
Meanwhile,
FDX1
knockdown
weakened
ability
promote
experiments,
effects.
These
indicated
rapidly
halted
growth
cells
line.
Importantly,
aerobic
targeting
GAPDH